With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

2.

Discovery of estrogen receptor 'switches' may aid breast cancer treatment

3.

Lower screening age calls for more tailored bowel cancer surveillance

4.

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

5.

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot